Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas.

Brain lesions caused by Cryptococcus neoformans or C. gattii (cryptococcomas) are typically difficult to diagnose correctly and treat effectively, but rapid differential diagnosis and treatment initiation are crucial for good outcomes. In previous studies, cultured cryptococcal isolates and ex vivo...

Descripción completa

Detalles Bibliográficos
Publicado en:Translational Research: The Journal of Laboratory & Clinical Medicine Vol. 230; pp. 111 - 123
Autores principales: Vanherp, Liesbeth, Poelmans, Jennifer, Weerasekera, Akila, Hillen, Amy, Croitor-Sava, Anca R, Sorrell, Tania C, Lagrou, Katrien, Vande Velde, Greetje, Himmelreich, Uwe
Formato: research Journal Article
Publicado: Elsevier B.V. Apr2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149013624&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 149013624
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19315244
        2Q66
      jtl: Translational Research: The Journal of Laboratory & Clinical Medicine
      issn: 19315244
      maglogo: N
    pubinfo:
      dt: Apr2021
      vid: 230
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        149013624
        149013624
        NLM33166695
        149013624
        10.1016/j.trsl.2020.11.001
        NLM33166695
        149013624
      ppf: 111
      ppct: 12
      formats:
      tig:
        atl: Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas.
      aug:
        au:
          Vanherp, Liesbeth
          Poelmans, Jennifer
          Weerasekera, Akila
          Hillen, Amy
          Croitor-Sava, Anca R
          Sorrell, Tania C
          Lagrou, Katrien
          Vande Velde, Greetje
          Himmelreich, Uwe
        affil: Biomedical MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
      sug:
        subj:
          Disaccharides Analysis
          Meningitis, Cryptococcal Diagnosis
          Meningitis, Cryptococcal Cerebrospinal Fluid
          Cryptococcus Drug Effects
          Human
          Animal Studies
          Mice
          Meningitis, Cryptococcal Blood
          Amphotericin B Pharmacodynamics
          Disaccharides Cerebrospinal Fluid
          Disaccharides Blood
          Drug Combinations
          Fluconazole Pharmacodynamics
          Meningitis, Cryptococcal Pathology
          Bile Acids and Salts Pharmacodynamics
          Female
          Cryptococcus Metabolism
          Middle Age
          Comparative Studies
          Multicenter Studies
          Evaluation Research
          Validation Studies
          Middle Aged: 45-64 years
          Female
      ab: Brain lesions caused by Cryptococcus neoformans or C. gattii (cryptococcomas) are typically difficult to diagnose correctly and treat effectively, but rapid differential diagnosis and treatment initiation are crucial for good outcomes. In previous studies, cultured cryptococcal isolates and ex vivo lesion material contained high concentrations of the virulence factor and fungal metabolite trehalose. Here, we studied the in vivo metabolic profile of cryptococcomas in the brain using magnetic resonance spectroscopy (MRS) and assessed the relationship between trehalose concentration, fungal burden, and treatment response in order to validate its suitability as marker for early and noninvasive diagnosis and its potential to monitor treatment in vivo. We investigated the metabolites present in early and late stage cryptococcomas using in vivo 1H MRS in a murine model and evaluated changes in trehalose concentrations induced by disease progression and antifungal treatment. Animal data were compared to 1H and 13C MR spectra of Cryptococcus cultures and in vivo data from 2 patients with cryptococcomas in the brain. In vivo MRS allowed the noninvasive detection of high concentrations of trehalose in cryptococcomas and showed a comparable metabolic profile of cryptococcomas in the murine model and human cases. Trehalose concentrations correlated strongly with the fungal burden. Treatment studies in cultures and animal models showed that trehalose concentrations decrease following exposure to effective antifungal therapy. Although further cases need to be studied for clinical validation, this translational study indicates that the noninvasive MRS-based detection of trehalose is a promising marker for diagnosis and therapeutic follow-up of cryptococcomas.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N